RecruitingNCT06480500

i-CBT and IV Ketamine for Suicidality in Treatment-Resistant Depression: A Randomized, Midazolam-Controlled Clinical Trial

This recruiting study focuses on depression and currently lists sites or participation links in Global.

DepressionOtherFrom 21 Years to 65 Years

In plain English

Key information made simple

This study exists to see whether cognitive behavioural therapy, a structured talking treatment, can play a useful role in care. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning. For people living with Depression, access and fit can matter just as much as the treatment itself. If the findings are useful, they could expand practical options that fit more easily into real life. Taking part helps build the evidence that can improve understanding and care for others over time.

What to expect

Your next step

The official record suggests a mix of remote and in-person participation through a hospital, with sites including Toronto General Hospital in Toronto. Participation appears to involve guided sessions or support activities with check-ins on how they fit into daily life. The main fit is usually being able to understand the study and consent and matching the main diagnosis, while common reasons not to take part include active substance or alcohol problems that could affect the results and major medical issues that could make participation unsuitable. This is an early-stage study, which usually means a smaller group and a focus on learning how the approach behaves.

Official source

Registry reference

This page links back to the public source record so people can verify details directly with the registry and research team.

If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.

Open source record

Interested?

Check my eligibility

Study reference: NCT06480500. Your email is the only field you need to provide here.

In practice

For you

Taking part may give access to a new approach being evaluated.

It requires regular follow-up, often through questionnaires or interviews.

Mixes in-person and remote participation.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com